The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment
about
Acute decompensated heart failure: contemporary medical managementAgents with vasodilator properties in acute heart failure: how to design successful trialsPermutation criteria to evaluate multiple clinical endpoints in a proof-of-concept study: lessons from Pre-RELAX-AHFAdenosine receptors as drug targets--what are the challenges?Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.Methylxanthines, seizures, and excitotoxicity.Diuretic use in heart failure and outcomes.The cardiorenal syndrome: a reviewInternational Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an updateEndogenous adenosine contributes to renal sympathetic neurotransmission via postjunctional A1 receptor-mediated coincident signaling.Caffeine prevents acute mortality after TBI in rats without increased morbidity.Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF)Introduction to adenosine receptors as therapeutic targets.The Impact of Worsening Heart Failure in the United StatesRole of A1 receptors in renal sympathetic neurotransmission in the mouse kidney.A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial of Aminophylline to Prevent Acute Kidney Injury in Children Following Congenital Heart Surgery With Cardiopulmonary Bypass.Vasodilators in the treatment of acute heart failure: what we know, what we don't.Emerging diuretics for the treatment of heart failure.End points for clinical trials in acute heart failure syndromes.A Phase 1 dose-ranging study examining the effects of a superabsorbent polymer (CLP) on fluid, sodium and potassium excretion in healthy subjectsThe current and future management of acute heart failure syndromes.Acute kidney injury in patients with decompensated heart failure.Cardiorenal syndrome: diagnosis, treatment, and clinical outcomes.Emerging therapies for heart failure: renal mechanisms and effects.Current treatment in acute and chronic cardio-renal syndrome.Heart failure in 2010: one step forward, two steps back.Can we improve the treatment of congestion in heart failure?Can we prevent or treat renal dysfunction in acute heart failure?Novel therapeutic targets for the treatment of heart failure.Renal dysfunction in acute heart failure: epidemiology, mechanisms and assessment.Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially.Medical therapy for acute decompensated heart failure: what recent clinical trials have taught us about diuretics and vasodilators.Efficacy and safety of loop diuretic therapy in acute decompensated heart failure: a clinical review.Pharmacological treatment of acute heart failure: current treatment and new targets.What's new in the treatment of acute heart failure?Changes in renal function in congestive heart failure.Increased mortality after an acute heart failure episode: new pathophysiological insights from the RELAX-AHF study and beyond.Implications of Using Different Definitions on Outcomes in Worsening Heart Failure.In-hospital worsening heart failure.Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.
P2860
Q24650932-D1F7462C-A272-4B18-AC82-F43F8C3901A9Q28084239-E600B48A-A0E8-4A4C-80CD-397B70619CA9Q28740781-A83876B4-D9C3-4429-BD07-8AE782D0E1EBQ29346491-73A96F44-3529-4B77-AFCD-9407BBA10F6FQ34148325-FCDE9B60-31CC-4643-9F18-DB814E7D2A52Q34154555-F6D2F5A5-B857-480E-83ED-4A15D3286684Q34357452-300DC438-9412-4713-90D7-85F9297D158CQ34495307-BA70A19C-4112-46D7-A93E-4E1A4BB0E8C1Q34701303-8F3F826A-7BA2-427F-BD49-8DC070ABB48CQ35787419-3519ED1E-46B8-4ADA-BBB1-89F49E3A6B8BQ35803244-77A83704-23CD-4430-9B23-8513C5E69086Q36089337-812733C2-6303-4068-AC48-667B904F955DQ36153376-33A9B76C-696F-42F9-9E92-9AD46AF0D10EQ36168137-25436C24-1D97-4F1E-840E-82984E89962DQ36312662-596E1DB8-6A01-4E46-B059-5461776D4E65Q36540621-9586B40F-01A9-4637-8209-A6474508061FQ37355110-3F6C0E0D-21FB-4D7B-A4EF-9A7833DEF817Q37386310-381D4E44-9A38-47E9-9571-7913E9F067B0Q37516738-D9F24F3E-BEE0-444B-9E8A-E41514DFACE6Q37518921-2ABBA5E4-46DB-4ACB-AF49-F1ACCD354950Q37703984-95190DC1-35EA-4566-8717-A01AEB21399AQ37744472-C08F3B6E-1EBA-4D9E-BC8A-0D8601C9FDDDQ37782283-693E039B-0A12-4A1B-95E6-EA615703DDC0Q37783956-86E9F674-140F-4035-8217-F6C583D1FB61Q37817025-4142932C-C0FC-4DC1-A2AE-3E6CBD6547DEQ37832649-13A6D32C-EAE7-4D94-8E0A-7BFDD131325EQ37845856-62CD2026-D853-422C-8C0F-995B903323BDQ37873812-0EFAFEE3-5FA8-4BBD-8C94-D6129B940AA6Q37893956-E1E3CE74-0AF0-4182-9CD8-2F0091A3CC52Q37900203-B26B0E37-0980-493B-80FA-8C9A913D0E02Q37913110-7A8BB2AF-91B4-4DD7-B4BC-498F0A477818Q37923340-25BE8D96-4BEA-4A55-AB34-C3751E74F414Q38058411-15DF46E6-43E7-4E9A-855F-92A63B3A204BQ38122297-11F858D7-F354-4533-AD69-E0E8F1A3D9A1Q38123740-98E69C26-4348-42CA-978C-5E6718EAB2ADQ38155422-1EB75620-1992-44F6-A172-C8CB02A867C8Q38173317-957D021A-5454-429B-A573-B17D8304BCAEQ38388972-BF2F9129-04D6-4F3F-BF8F-A31DC9653BEBQ38559347-AD3E78A5-E268-4DBD-A1B6-343622A5B7ACQ38705811-F7B6AD0C-7986-4E7B-BCB2-E5A57021FE8E
P2860
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The PROTECT pilot study: a ran ...... t failure and renal impairment
@ast
The PROTECT pilot study: a ran ...... t failure and renal impairment
@en
The PROTECT pilot study: a ran ...... t failure and renal impairment
@nl
type
label
The PROTECT pilot study: a ran ...... t failure and renal impairment
@ast
The PROTECT pilot study: a ran ...... t failure and renal impairment
@en
The PROTECT pilot study: a ran ...... t failure and renal impairment
@nl
prefLabel
The PROTECT pilot study: a ran ...... t failure and renal impairment
@ast
The PROTECT pilot study: a ran ...... t failure and renal impairment
@en
The PROTECT pilot study: a ran ...... t failure and renal impairment
@nl
P2093
P50
P921
P1476
The PROTECT pilot study: a ran ...... t failure and renal impairment
@en
P2093
Barry M Massie
Beth Davison Weatherley
Daniel M Bloomfield
Howard C Dittrich
P304
P356
10.1016/J.CARDFAIL.2008.08.010
P407
P577
2008-10-01T00:00:00Z